{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:18:02Z","timestamp":1787008682990,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemoradiotherapy using proton beam therapy is a novel and promising option for patients with esophageal squamous cell carcinoma (ESCC) who do not prefer surgical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This was a single-center retrospective cohort study. Patients diagnosed with thoracic ESCC, clinical Stages I, II, or III, who underwent definitive proton-based chemoradiotherapy (PBC) or surgery-based treatment (SBT) between 2009 and 2020 were included. Patients intolerant to surgery or palliative radiotherapy were excluded. PBC was defined as radical-intent chemoradiotherapy using a proton beam with chemotherapy, and a combination of photon radiation was allowed. SBT was defined as subtotal esophagectomy with lymph node dissection with or without adjuvant chemotherapy. The propensity score matching was performed using potential confounding factors as covariates. The primary endpoints were the hazard ratio (HR) and 5-year overall survival (5yOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 247 patients (112 with SBT and 135 with PBC). Survival outcomes were compared between the 95 patients in each group using propensity score matching. The mean observation period was 57.5\u00a0months. The 5yOS was 62.0% in the SBT and 55.3% in the PBT group (P\u2009=\u20090.421). The adjusted HR for PBC was 1.22 (0.79\u20131.90). No treatment-related deaths occurred in the PBC group. Serious adverse events included neutropenia (n\u2009=\u20095), esophageal ulcer (n\u2009=\u20093) in the early phase, and esophageal fistula (n\u2009=\u20093), pleural effusion (n\u2009=\u20091), and pericardial effusion (n\u2009=\u20091) in the late phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Radical chemoradiotherapy using proton beams is a promising treatment option for patients with ESCC who do not prefer surgery in terms of safety and efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/dote\/doaf099","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:28:26Z","timestamp":1763044106000},"source":"Crossref","is-referenced-by-count":1,"title":["Proton beam-based chemoradiotherapy versus surgery plus adjuvant chemotherapy for esophageal squamous cell carcinoma: a comparison of the long-term survival from a single-center cohort study"],"prefix":"10.1093","volume":"38","author":[{"given":"Satoshi","family":"Toshiyama","sequence":"first","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]},{"name":"Department of Surgery, Southern TOHOKU General Hospital , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-9881","authenticated-orcid":false,"given":"Michitaka","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]},{"name":"Department of Surgery, Southern TOHOKU General Hospital , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-0337","authenticated-orcid":false,"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-5877","authenticated-orcid":false,"given":"Motohisa","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]},{"name":"Department of Surgery, Southern TOHOKU General Hospital , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takagawa","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]},{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-5125","authenticated-orcid":false,"given":"Hisashi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern TOHOKU Proton Therapy Center , Koriyama ,","place":["Japan"]},{"name":"Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University , Fukushima ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Southern TOHOKU General Hospital , Koriyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-1610","authenticated-orcid":false,"given":"Soshi","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , Fukushima ,","place":["Japan"]},{"name":"Department of Surgery, Kansai Medical University , Hirakata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kansai Medical University , Hirakata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University , Fukushima ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"24","key":"2025111309282328700_ref1","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1200\/JCO.2003.12.095","article-title":"Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study\u2014JCOG9204","volume":"21","author":"Ando","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025111309282328700_ref2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","article-title":"A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)","volume":"19","author":"Ando","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"10447","key":"2025111309282328700_ref3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","article-title":"Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial","volume":"404","author":"Kato","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"2025111309282328700_ref4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ases.12681","article-title":"Recent advances in thoracoscopic esophagectomy for esophageal cancer","volume":"12","author":"Booka","year":"2019","journal-title":"Asian J Endosc Surg"},{"issue":"7","key":"2025111309282328700_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae143","article-title":"Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)","volume":"111","author":"Chao","year":"2024","journal-title":"Br J Surg"},{"issue":"7","key":"2025111309282328700_ref6","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1245\/s10434-017-5808-4","article-title":"Comparison of short-term outcomes between open and minimally invasive esophagectomy for Esophageal cancer using a Nationwide database in Japan","volume":"24","author":"Takeuchi","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"2025111309282328700_ref7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced Esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"9","key":"2025111309282328700_ref8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00066-010-2079-4","article-title":"Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer","volume":"186","author":"Mizumoto","year":"2010","journal-title":"Strahlenther Onkol"},{"issue":"23","key":"2025111309282328700_ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235524","article-title":"Treatment outcomes of proton beam therapy for Esophageal squamous cell carcinoma at a single institute","volume":"15","author":"Oh","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2025111309282328700_ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070993","article-title":"Clinical results of proton beam therapy for Esophageal cancer: multicenter retrospective study in Japan","volume":"11","author":"Ono","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2025111309282328700_ref11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jjco\/hyw102","article-title":"Proton beam therapy in Japan: current and future status","volume":"46","author":"Sakurai","year":"2016","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"2025111309282328700_ref12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10388-020-00715-y","article-title":"Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence","volume":"17","author":"Sato","year":"2020","journal-title":"Esophagus"},{"issue":"3","key":"2025111309282328700_ref13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2017.06.2450","article-title":"Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for Esophageal cancer: a retrospective, single-institutional analysis","volume":"99","author":"Xi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2025111309282328700_ref14","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s10147-021-01981-1","article-title":"Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma","volume":"26","author":"Ogawa","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"2025111309282328700_ref15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s10388-024-01068-6","article-title":"Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study","volume":"21","author":"Ogawa","year":"2024","journal-title":"Esophagus"},{"issue":"11","key":"2025111309282328700_ref16","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1245\/s10434-020-09545-9","article-title":"Prognostic significance of the number and extent of metastatic lymph nodes in patients with esophageal cancer: comparison of the Union for International Cancer Control 8th Edition and Japan Esophageal Society Japanese Classification of Esophageal Cancer 11th Edition Classifications for Esophageal Cancer","volume":"28","author":"Ozawa","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2025111309282328700_ref17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1515\/raon-2015-0034","article-title":"Clinical results of proton beam therapy for twenty older patients with esophageal cancer","volume":"49","author":"Ono","year":"2015","journal-title":"Radiol Oncol"},{"issue":"4","key":"2025111309282328700_ref18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ejhf.1376","article-title":"The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer","volume":"21","author":"Mansouri","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"2025111309282328700_ref19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"2025111309282328700_ref20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"2025111309282328700_ref21","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.ijrobp.2012.01.003","article-title":"Proton beam therapy and concurrent chemotherapy for esophageal cancer","volume":"83","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2025111309282328700_ref22","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1111\/1759-7714.13524","article-title":"Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma","volume":"11","author":"Ono","year":"2020","journal-title":"Thorac Cancer"},{"issue":"16","key":"2025111309282328700_ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164045","article-title":"Proton beam therapy for esophageal cancer","volume":"14","author":"Solidum","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2025111309282328700_ref24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/ejcts\/ezs136","article-title":"Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma","volume":"42","author":"Li","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"2025111309282328700_ref25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s12029-019-00337-3","article-title":"Pretreatment esophageal wall thickness associated with response to chemoradiotherapy in locally advanced esophageal cancer","volume":"51","author":"Wongwaiyut","year":"2020","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"2025111309282328700_ref26","first-page":"1757","article-title":"Proton beam therapy combined with concurrent chemotherapy for esophageal cancer","volume":"35","author":"Ishikawa","year":"2015","journal-title":"Anticancer Res"},{"issue":"8","key":"2025111309282328700_ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14082033","article-title":"A comparative analysis of photon versus proton beam therapy in neoadjuvant concurrent chemoradiotherapy for intrathoracic squamous cell carcinoma of the esophagus at a single institute","volume":"14","author":"Choi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2025111309282328700_ref28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cam4.607","article-title":"Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer","volume":"5","author":"Takada","year":"2016","journal-title":"Cancer Med"},{"issue":"4","key":"2025111309282328700_ref29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10388-023-01015-x","article-title":"Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review","volume":"20","author":"Nonaka","year":"2023","journal-title":"Esophagus"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/6\/doaf099\/65282565\/doaf099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/6\/doaf099\/65282565\/doaf099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:28:27Z","timestamp":1763044107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doaf099\/8322345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doaf099","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,1]]},"article-number":"doaf099"}}